Vasculitis & polymyalgia rheumatica
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update
Methodological detailsguideline update, systematic literature review update, expert consensus, anonymous voting, Task force of 24 physicians, health professionals and patients from 14 countries
- Guideline update
- Systematic literature review update
- Expert consensus
- Anonymous voting
- Task force of 24 physicians, health professionals and patients from 14 countries
Recommendations
As issued by the authors
US is now recommended as first-line imaging test in all patients with suspected GCA; axillary arteries should be included in the standard examination
As an alternative to US, cranial and extracranial arteries can be examined by fluorodeoxyglucose positron emission tomography (FDG-PET) or MRI
For TAK, MRI is the preferred imaging modality; FDG-PET, CT or US are alternatives
Imaging is not routinely recommended for follow-up; US, FDG-PET or MRI may be used to assess vessel abnormalities in large vessel vasculitis (LVV) with suspected relapse, particularly when laboratory markers of inflammation are unreliable
MR-angiography, CT-angiography or US may be used for long-term monitoring of structural damage, particularly at sites of preceding vascular inflammation
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →